Clinical Trial Update: The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Ornithine Aspartic Acid Granules to Silymarin Capsules in non-alcoholic fatty liver disease completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Ornithine Aspartic Acid Granules (ornithine aspartate granules)
• Silymarin Capsules (silymarin)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Non-alcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED